成人人类免疫缺陷病毒感染者新型冠状病毒疫苗接种专家建议  

Expert recommendation for novel severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)vaccination in patients with HIV infection

作　　者：中华医学会感染病学分会艾滋病丙型肝炎学组 李太生[2,3] 卢洪洲 李倩[4] 曹玮 林逸骁[4] 林铃 沈银忠[4] AIDS and Hepatitis C Professional Group,Chinese Society of Infectious Diseases;Li Taisheng;Lu Hongzhou(不详;Department of Infectious Diseases,Peking Union Medical College Hospital,Peking Union Medical College,Chinese Academy of Medical Sciences,Beijing 100730,China;Department of Basic Medical Sciences,Tsinghua University School of Medicine,Beijing 100084,China;Department of Infection and Immunity,Shanghai Public Health Clinical Center,Shanghai Medical College,Fudan University,Shanghai 201508,China)

机构地区：[1]不详 [2]中国医学科学院,北京协和医学院,北京协和医院感染内科,100730 [3]清华大学医学院基础医学系,北京100084 [4]复旦大学医学院上海市公共卫生临床中心感染与免疫科,201508

出　　处：《中华内科杂志》2021年第7期615-618,共4页Chinese Journal of Internal Medicine

基　　金：“十三五”国家科技重大专项(2017ZX10202101);上海市2020年度“科技创新行动计划”医学创新研究专项(20Z11900900)。

摘　　要：新型冠状病毒(SARS-CoV-2)感染导致的新型冠状病毒肺炎疫情自2019年底出现后已进入全球大流行,自2020年末SARS-CoV-2疫苗(新冠疫苗)接种正在全球范围内积极推进,成为控制疫情的重要措施。人类免疫缺陷病毒(HIV)感染者受其基础感染影响,存在不同程度的免疫缺陷及慢性炎症,接种疫苗的种类和时机均需结合临床具体情况来确定。本专家建议对HIV感染者新冠疫苗的接种提供具体建议。The outbreak of coronavirus disease 2019(COVID-19)caused by novel severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has become a global pandemic.SARS-CoV-2 vaccination is currently being actively promoted all over the world,which would serve a promising measure to combat the epidemic.HIV-infected patients manifest varying degrees of immunodeficiency and chronic inflammation,who may require a special consideration on vaccine types and timing of immunization depending on specific clinical situations.The present recommendation provides reference for SARS-CoV-2 vaccination in HIV-infected patients.

关 键 词：疫苗 新型冠状病毒 HIV感染 

分 类 号：R186[医药卫生—流行病学] R512.91[医药卫生—公共卫生与预防医学]